China Universal Asset Management Co., Ltd. - THERAVANCE BIOPHARMA INC ownership

THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 114 filers reported holding THERAVANCE BIOPHARMA INC in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.4%.

Quarter-by-quarter ownership
China Universal Asset Management Co., Ltd. ownership history of THERAVANCE BIOPHARMA INC
ValueSharesWeighting
Q3 2023$12
+50.0%
1,357
+79.3%
0.00%
+50.0%
Q2 2023$8
-20.0%
757
-17.1%
0.00%
-33.3%
Q1 2023$10
+25.0%
913
+33.5%
0.00%0.0%
Q4 2022$8
-99.9%
684
-4.5%
0.00%0.0%
Q3 2022$7,0007160.00%
Other shareholders
THERAVANCE BIOPHARMA INC shareholders Q1 2023
NameSharesValueWeighting ↓
Chescapmanager LLC 1,134,718$23,160,0002.47%
Baupost Group 8,735,168$178,285,0001.42%
Orbimed Advisors 6,219,110$126,932,0001.19%
CM Management, LLC 50,000$1,021,0000.76%
Tekla Capital Management LLC 456,296$9,313,0000.32%
Rock Springs Capital Management LP 682,600$13,932,0000.30%
Virtus ETF Advisers LLC 32,871$671,0000.28%
Cormorant Asset Management, LP 550,000$11,226,0000.25%
DAFNA Capital Management LLC 41,165$840,0000.20%
PEREGRINE CAPITAL MANAGEMENT LLC 484,206$9,883,0000.18%
View complete list of THERAVANCE BIOPHARMA INC shareholders